Sitagliptin protects proliferation of neural progenitor cells in diabetic mice
- 20 February 2015
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 30 (4) , 885-893
Abstract
Sitagliptin (SIT) is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances the effects of incretin hormones, such as Glucose-dependent Insulinotropic Peptide (also known as Gastric Inhibitory Polypeptide, GIP) and Glucagon-Like Peptide 1 (GLP-1). We have now evaluated the effect of SIT on proliferation of neural progenitors in diabetic mice. A condition resembling the non-obese type 2 diabetes mellitus (D2) was achieved by a combination of streptozotocin and nicotinamide (NA-STZ), whereas a type 1-like disease (D1) was provoked by STZ without NA. Non-diabetic mice received vehicle injections. Cell proliferation was estimated by bromodeoxyuridine (BrdU) incorporation in two different regions of the subventricular zone (SVZ), the largest reserve of neural stem cells in the adult brain. SIT treatment did not modify the high fasting blood glucose (BG) levels and intraperitoneal glucose tolerance test (IPGTT) of D1 mice. By contrast, in D2 mice, SIT treatment significantly reduced BG and IPGTT. Both D1 and D2 mice showed a substantial reduction of BrdU labeling in the SVZ. Remarkably, SIT treatment improved BrdU labeling in both conditions. Our findings suggest that SIT would protect proliferation of neural progenitor cells even in the presence of non-controlled diabetic alterations.Keywords
This publication has 73 references indexed in Scilit:
- DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant ratsJournal of Endocrinology, 2013
- Diabetes as a risk factor for dementia and mild cognitive impairment: a meta‐analysis of longitudinal studiesInternal Medicine Journal, 2012
- Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic ratsClinical Science, 2012
- Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trialDiabetic Medicine, 2011
- Endothelinergic signaling during recovery of brain cortical lesionsNeurological Research, 2011
- Hippocampal neurovascular and hypothalamic–pituitary–adrenal axis alterations in spontaneously type 2 diabetic GK ratsExperimental Neurology, 2010
- Impact of impaired glucose tolerance and type 2 diabetes on cognitive agingNeurobiology of Aging, 2005
- Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in the Pathogenesis of Type 2 DiabetesDiabetes, 2004
- Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated miceBrain Research, 2002
- Running enhances neurogenesis, learning, and long-term potentiation in miceProceedings of the National Academy of Sciences, 1999